Last month's settlement of the quantitative computed tomography(QCT) patent dispute between Image Analysis and GE Medical Systemstransformed the two competitors into future partners. The firmsreached a verbal agreement to form an alliance, according to
Last month's settlement of the quantitative computed tomography(QCT) patent dispute between Image Analysis and GE Medical Systemstransformed the two competitors into future partners. The firmsreached a verbal agreement to form an alliance, according to BenA. Arnold, Image Analysis president.
Arnold sued GE in October 1990, alleging patent infringementin the design of a phantom used in converting standard CT systemsto measure bone mass. QCT competes with dual-energy x-ray absorptiometry(DEXA) systems in the diagnosis of osteoporosis.
Image Analysis of Irvine, CA, won a preliminary injunctionfrom Santa Ana, CA, Federal District Court in March prohibitingGE from marketing, using or selling its QCT phantom (SCAN 3/27/91).The ruling withstood GE's subsequent challenge.
"With that, it became clear to both sides that we oughtto be friends," Arnold said.
GE agreed to stop selling its own QCT systems in the U.S.,Japan and Europe, offering Image Analysis phantoms and softwareinstead, he said. A GE spokesperson verified that a preliminaryagreement had been reached. GE is withholding further commentuntil terms are finalized.
The settlement will be pivotal for the future of Image Analysis,a $3-million-a-year company. Domestic sales of the firm's $15,000QCT system slumped after GE's product was introduced in 1988,Arnold said.
Image Analysis has sold 700 systems since its formation in1984. It is responsible for the lion's share of the internationalinstalled base, according to Arnold. Siemens may have sold over500 systems, while GE's share is estimated at 300 to 400 systems.
"As of right now, I'm going to be offering my productto GE, and they're postponing their project worldwide. I'm reallyhappy about that," Arnold said.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.